June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Effect of sclerotomy location on post operative outcomes in scleral sutured intraocular lens (SSIOL)
Author Affiliations & Notes
  • Ernesto Andres Sabogal
    University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
  • Shalini Shah
    University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
  • Mona L Camacci
    University of Rochester David and Ilene Flaum Eye Institute, Rochester, New York, United States
  • Gilbert Smolyak
    University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
  • Rajeev S Ramchandran
    University of Rochester David and Ilene Flaum Eye Institute, Rochester, New York, United States
  • David Allen DiLoreto
    University of Rochester David and Ilene Flaum Eye Institute, Rochester, New York, United States
  • Vamsi Gullapalli
    University of Rochester David and Ilene Flaum Eye Institute, Rochester, New York, United States
  • Footnotes
    Commercial Relationships   Ernesto Sabogal None; Shalini Shah None; Mona Camacci None; Gilbert Smolyak None; Rajeev Ramchandran None; David DiLoreto None; Vamsi Gullapalli None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5288. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ernesto Andres Sabogal, Shalini Shah, Mona L Camacci, Gilbert Smolyak, Rajeev S Ramchandran, David Allen DiLoreto, Vamsi Gullapalli; Effect of sclerotomy location on post operative outcomes in scleral sutured intraocular lens (SSIOL). Invest. Ophthalmol. Vis. Sci. 2023;64(8):5288.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To compare post operative outcomes of scleral suturing of intraocular lenses (SSIOLs) at 2.5 or 3 mm posterior to the limbus to mimic either a sulcus implanted lenses or a lens placed within the bag, respectively.

Methods : This is a single-center, retrospective case series analysis of data collected from an IRB approved surgical database of all retinal surgeries performed at Strong Hospital, University of Rochester, from 2020 to 2022. Eyes that underwent scleral fixated intraocular lens placement of enVista MX60E using Gore-Tex suture performed by three vitreoretinal surgeons were included. Outcome measures included postoperative changes in visual acuity (VA), ocular pain, (classified as requiring and not requiring adjustment in management, and no pain), elevated intraocular pressure (IOP >21), hypotony (IOP <5), retinal detachment (RD), and cystoid macular edema (CME). Statistical analysis was performed with a Chi squared test for association or Fisher’s exact test when appropriate performed using R studio.

Results : Of 90 patients (90 eyes), 70 (78%) had SSIOL placed 3 mm from the limbus and 20 (22%) at 2.5 mm. Examination of surgeon-specific breakdown revealed that 3 surgeons performed 51 cases (19 and 42 receiving 2.5 and 3 mm SSIOL placement respectively), 17 cases (1 and 16), and 12 cases (0 and 12). Thirteen (65%) patients in the 2.5 mm group and 47 (67%) in the 3 mm group experienced at least one complication up to three months post-op. There were no statistically significant associations between SSIOL placement at 2.5 vs 3 mm from the limbus and frequency or type of post-op complications including CME, RD, hypotony, elevated IOP, or ocular pain up to three months post-op (Table 1). There were 46 patients who had VA data recorded at 2-3 months post-op. There was no significant difference between VA improvement or impairment for patients in the 2.5 or 3 mm groups from pre-op best corrected VA (Table 2); the remaining 4 patients, all in the 3 mm group, did not experience any worsening in VA.

Conclusions : Placing an MX60E SSIOL at 2.5 or 3 mm from the limbus does not appear to affect post-op visual acuity and ocular complications.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Table 1: All patients who experienced a complication following SSIOL placement or had pain requiring change in management. 70 and 20 patients in 3 and 2.5 mm groups respectively

Table 1: All patients who experienced a complication following SSIOL placement or had pain requiring change in management. 70 and 20 patients in 3 and 2.5 mm groups respectively

 

Table 2: All patients who had VA data at both a preop visit and at a POM 2-3 visit.

Table 2: All patients who had VA data at both a preop visit and at a POM 2-3 visit.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×